According to the recommendations of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), Glupa-c is used in diagnostic tests for the determination of γ-glutamyltransferase for the quantitatively detect the activity in human serum or plasma.

Molecular formula: C12H16N4O7
Molecular weight: 328.28
Purity: >99 %
Detection Wavelength: λ max= 405 nm
Storage：2-8℃, For long term use store at -20℃. Please keep it in dry and dark place. Avoid light.
Shelf life：2 Years

The Role of γ-Glutamyltransferase (GGT) in Clinical Diagnostics

Understanding γ-Glutamyltransferase (GGT)

γ-Glutamyltransferase (GGT) is an enzyme that plays a crucial role in the metabolism of glutathione, an important antioxidant that helps protect cells from oxidative stress. GGT is found in many tissues throughout the body, but its highest concentrations are in the liver, bile ducts, and kidneys. Due to its significant presence in the liver, GGT is often used as a biomarker for liver function.

Elevated levels of GGT in the blood are indicative of liver damage, bile duct obstruction, or other hepatobiliary disorders. It can also be elevated in cases of chronic alcohol consumption, certain medications, and conditions such as pancreatitis or congestive heart failure. Thus, accurate measurement of GGT activity is essential for diagnosing and monitoring these conditions

The Importance of Accurate GGT Measurement

Given the critical role of GGT in diagnosing liver and bile duct conditions, the accuracy of its measurement is of utmost importance. Inaccurate results could lead to misdiagnosis, inappropriate treatment, and poor patient outcomes. This is where substrates like Glupa-C come into play. By providing a reliable means to measure GGT activity, Glupa-C contributes to the overall accuracy and effectiveness of diagnostic tests.

Glupa-C: Molecular Properties and Characteristics

Molecular Formula and Weight

Glupa-C has the molecular formula C12H16N4O7 and a molecular weight of 328.28 g/mol. Its structure is specifically designed to act as a substrate for GGT, allowing for precise quantification of the enzyme’s activity in serum or plasma samples.

Purity and Sensitivity

One of the key attributes of Glupa-C is its high purity, with a specification of over 99%. This high level of purity ensures that the substrate provides consistent and reliable results in diagnostic assays. The presence of impurities could potentially interfere with the assay, leading to inaccurate readings. With Glupa-C, medical institutions can be confident in the substrate’s ability to deliver precise measurements.

Moreover, Glupa-C is known for its high sensitivity, which is crucial for detecting even low levels of GGT activity. This sensitivity is particularly important in clinical settings where early detection of abnormal GGT levels can lead to timely intervention and better patient outcomes.

Detection Wavelength and Stability

Glupa-C is designed to be detected at a wavelength (λ max) of 405 nm. This specific detection wavelength is chosen to optimize the assay’s sensitivity and accuracy, ensuring that even small changes in GGT activity can be accurately measured.

In terms of stability, Glupa-C exhibits excellent properties. It is stable under recommended storage conditions, maintaining its efficacy over time. This stability is critical for laboratories that require reliable reagents that do not degrade or lose potency during storage.

Storage Conditions and Shelf Life

To maintain its stability and effectiveness, Glupa-C should be stored at temperatures between 2-8°C for short-term use. For long-term storage, it is recommended to store the substrate at -20°C. It is also essential to keep Glupa-C in a dry and dark place, as exposure to light and moisture can degrade the substrate and reduce its shelf life.

When stored properly, Glupa-C has a shelf life of two years. This extended shelf life allows laboratories to stock the substrate without the concern of it expiring quickly, making it a cost-effective choice for ongoing diagnostic testing.

Applications of Glupa-C in Clinical Diagnostics

Use in In Vitro Diagnostic Tests

Glupa-C is primarily used in in vitro diagnostic (IVD) tests for the quantitative detection of GGT activity in human serum or plasma. These tests are performed in a controlled laboratory environment, where the substrate is added to the sample, and the resulting enzymatic reaction is measured.

The use of Glupa-C in these tests ensures that the GGT activity is accurately quantified, providing valuable information for the diagnosis and monitoring of liver and biliary disorders. By using a high-quality substrate like Glupa-C, laboratories can ensure that their diagnostic tests are both reliable and reproducible.

Benefits of Using Glupa-C in Diagnostic Testing

There are several benefits to using Glupa-C in diagnostic testing:

– Good Water Solubility: Glupa-C is highly soluble in water, making it easy to prepare and use in assays. This solubility ensures that the substrate is evenly distributed in the reaction mixture, leading to consistent results.
– High Sensitivity: As mentioned earlier, Glupa-C is highly sensitive, allowing for the detection of even low levels of GGT activity. This sensitivity is critical for early diagnosis and monitoring of diseases.
– Linearity: Glupa-C exhibits a linear response over a wide range of GGT concentrations. This linearity ensures that the assay can accurately measure GGT activity across different levels, from low to high, without losing accuracy.
– Good Stability: The stability of Glupa-C under recommended storage conditions ensures that the substrate remains effective over time. This stability is essential for laboratories that need reliable reagents for ongoing testing.

The Role of Glupa-C in Improving Diagnostic Accuracy

Enhancing Laboratory Efficiency

The use of Glupa-C in diagnostic tests not only improves the accuracy of GGT measurement but also enhances overall laboratory efficiency. With its high purity, stability, and sensitivity, Glupa-C reduces the likelihood of assay errors and the need for repeat testing. This efficiency translates to faster turnaround times for test results, allowing clinicians to make timely decisions about patient care.

Supporting Clinical Decision-Making

Accurate measurement of GGT activity is crucial for diagnosing and monitoring various liver and biliary conditions. By providing reliable and consistent results, Glupa-C supports clinicians in making informed decisions about patient treatment and management. Whether it’s detecting early signs of liver damage or monitoring the effectiveness of treatment, the accurate data provided by Glupa-C-based assays is invaluable in the clinical setting.

Contribution to Research and Development

In addition to its use in routine diagnostic testing, Glupa-C also plays a role in research and development. Researchers studying liver function, enzyme activity, and related fields can rely on Glupa-C to provide accurate and reproducible results. This contribution to scientific research helps advance our understanding of liver diseases and the development of new diagnostic and therapeutic approaches.

The Future of Diagnostic Testing with Glupa-C

Innovations in In Vitro Diagnostics

As the field of in vitro diagnostics continues to evolve, the demand for high-quality substrates like Glupa-C will only increase. Innovations in assay technology, combined with the need for more precise and sensitive diagnostic tests, will drive the development and adoption of advanced substrates that can meet these challenges.

Glupa-C is well-positioned to play a key role in this future. Its proven track record of reliability and accuracy makes it a trusted choice for laboratories and medical institutions worldwide. As new diagnostic technologies emerge, Glupa-C will continue to be an essential component of assays designed to measure GGT activity and other critical biomarkers.

Expanding Applications Beyond GGT Measurement

While Glupa-C is primarily used for GGT measurement, its properties make it a versatile substrate that could potentially be adapted for other diagnostic applications. Research into new uses for Glupa-C could lead to the development of novel assays that target different enzymes or biomarkers, further expanding its utility in clinical diagnostics.

Collaboration with Medical Institutions and Researchers

Hzymes Biotech, the manufacturer of Glupa-C, is committed to collaborating with medical institutions and researchers to further improve and expand the use of this substrate in diagnostic testing. By working closely with experts in the field, Hzymes can continue to refine Glupa-C and develop new products that meet the evolving needs of the clinical diagnostics industry.

Conclusion

In the world of clinical diagnostics, the importance of accurate and reliable testing cannot be overstated. Glupa-C, as recommended by the IFCC, has proven to be an invaluable substrate for the quantitative detection of GGT activity in human serum or plasma. Its molecular properties, high purity, sensitivity, and stability make it an ideal choice for laboratories and medical institutions seeking to improve the accuracy and efficiency of their diagnostic tests.

As the field of in vitro diagnostics continues to advance, Glupa-C will remain at the forefront of innovation, providing the quality and consistency needed to support accurate clinical decision-making. Whether used in routine testing, research, or the development of new diagnostic assays, Glupa-C is a testament to the power of precision in modern medicine.

For laboratories and researchers looking for a reliable, high-quality substrate for their GGT assays, Glupa-C represents the pinnacle of excellence. With its proven track record and ongoing commitment to quality, Hzymes Biotech is proud to offer Glupa-C as a key component of your in vitro diagnostic solutions.

In the future, Hzymes biotech will always remember its original intention and persist in meticulous cultivation in the IVD field. It will adhere to independent research and development, accelerate the construction of a world-class specialty enzyme production platform, and achieve import substitution of core enzyme raw materials in the field of biomedicine in China. It will collaborate with leading biopharmaceutical companies to expand their global presence and contribute to the advancement of the industry.